[1] |
Hammes HP, Feng Y, Pfister F, et al. Diabetic retinopathy: targeting vasoregression. Diabetes,2011,60:9-16.
|
[2] |
Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol,2004, 287:572-579.
|
[3] |
Bhatwadekar AD, Glenn JV, Li G, et al. Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy. Invest Ophthalmol Vis Sci,2008,49:1232-1241.
|
[4] |
Muranaka K, Yanagi Y, Tamaki Y, et al. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Invest Ophthalmol Vis Sci,2006,47:4547-4552.
|
[5] |
Li Calzi S, Neu MB, Shaw LC, et al. Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits. EPMA J,2010, 1:88-100.
|
[6] |
Harraz M, Jiao C, Hanlon HD, et al.CD34-blood-derived human endothelial cells progenitors. Stem Cells,2001,19:304-312
|
[7] |
Rustemeyer P, Wittkowski W, Jurk K, et al. Optimized flow cytometric analysis of endothelial progenitor cells in peripheral blood. J Immunoassay Immunochem,2006,27:77-88.
|
[8] |
Masaaki Ii. Bone marrow-derived endothelial progenitor cells: isolation and characterization for myocardial repair. Methods Mol Biol,2010,660:9-27.
|
[9] |
彭晓燕,陈大年. 血管内皮生长因子和眼内新生血管. 中华眼底病杂志,1999,15:62.
|
[10] |
焦明菲,颜华. 糖尿病视网膜病变对大鼠循环外周血内皮祖细胞数量的影响. 中华眼底病杂志,2011,27:250-254.
|
[11] |
Menegazzo L, Albiero M, Avogaro A, et al. Endothelial progenitor cells in diabetes mellitus. Biofactors,2012,38:194-202.
|
[12] |
El-Remessy AB, Bartoli M, Platt DH, et a1. Oxidative stress inactirates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci,2005,118:243-252.
|
[13] |
Hfistov M, Erl R, Weber PC. Endothelial progenitor cells mobilization, differentiation, and homing. Arterioscler Thromb Vasc Bio,2003,23:1185-1189.
|
[14] |
Brunner S, Schemthaner GH, Salter M, et al. Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data. Invest Ophthalmol Vis Sci,2009,50:392-398.
|
[15] |
Asnaghi V, Lattanzio R, Mazzolari G, et al. Increased clonogenic potential of circulating endothelial progenitor cells in patients with type 1 diabetes and proliferative retinopathy. Diabetologia,2006,49:1109-1111.
|
[16] |
Kramerov A, Saghizadeh M, Caballero S. Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites. Mol Cell Biochem,2008,316:177-186.
|
[17] |
Caballero S, Sengupta N, Afzal A, et al. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes,2007,56:960-967.
|
[18] |
Li Calzi S, Neu MB, Shaw LC, et al. EPCs and pathological angiogenesis: when good cells go bad. Microvasc Res,2010, 79:207-216.
|